Showing results (111-120 of 432) with videos related to

Sort By:
Pageof 44
Cancer Research|September 7, 2007
Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progressionYue He, Omar E Franco, Ming Jiang, et al.
Cancer Research|January 21, 2006
Increased expression of osteopontin contributes to the progression of prostate cancerAni C Khodavirdi, Zhigang Song, Shangxin Yang, et al.
Genomics|August 9, 2003
Isolation and characterization of human and mouse WDR19,a novel WD-repeat protein exhibiting androgen-regulated expression in prostate epitheliumBiaoyang Lin, James T White, Angelita G Utleg, et al.
American Journal of Epidemiology|August 7, 2010
Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer riskClaudia A Salinas, Erika M Kwon, Liesel M FitzGerald, et al.
The Prostate|March 17, 2006
KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cellsWei Lu, Daixing Zhou, Gustavo Glusman, et al.
The Prostate|February 19, 2020
A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironmentsLauren Brady, Rui M Gil da Costa, Ilsa M Coleman, et al.
Plos One|January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculatureMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.
Cancers|December 7, 2017
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and QuestionsOsama S Mohammad, Michael D Nyquist, Michael T Schweizer, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genesIlsa M Coleman, Jeffrey A Kiefer, Lisha G Brown, et al.
Pageof 44